Phospho-PHB (Thr258) Antibody

What is PHB and why is its phosphorylation at Thr258 significant?

Prohibitin 1 (PHB or PHB1) is a highly conserved, multifunctional protein that plays crucial roles in mitochondrial integrity, cell proliferation, and transcriptional regulation. PHB contains multiple phosphorylation sites, with Thr258 being particularly significant as it conforms to the optimal Akt motif RXRXXp(S/T) . This specific phosphorylation site is located within a region crucial for PHB's functional properties.

The phosphorylation at Thr258 is mediated by Akt and significantly affects PHB's subcellular localization and function. Research has demonstrated that this specific post-translational modification is essential for PHB's mitochondrial localization and its role in promoting cell proliferation, particularly in cancer cells . Understanding this phosphorylation is critical as it represents a key regulatory mechanism that modulates PHB's diverse cellular functions.

What are the optimal applications for Phospho-PHB (Thr258) antibodies?

Phospho-PHB (Thr258) antibodies are primarily optimized for Western blotting (WB) applications with recommended dilutions of 1:500~1:1000 . These antibodies specifically detect endogenous levels of PHB only when phosphorylated at threonine 258, making them valuable tools for studying Akt-mediated signaling pathways .

For optimal results in experimental applications, researchers should consider the following:

• Western blotting: The antibody can be used to detect phosphorylated PHB in whole cell lysates, subcellular fractions, or immunoprecipitated samples.

• Immunoprecipitation: Combined with Western blotting to enrich for phosphorylated PHB.

• Subcellular localization studies: To investigate the distribution of phosphorylated PHB in different cellular compartments.

It's important to note that according to the product specifications, the antibody has demonstrated reactivity with human, mouse, and rat samples .

How should researchers prepare samples for optimal detection of Phospho-PHB (Thr258)?

For effective detection of Phospho-PHB (Thr258) in research samples, the following methodological considerations are essential:

• Lysis buffer composition: Use phosphate buffered saline containing phosphatase inhibitors to prevent dephosphorylation of PHB during sample preparation.

• Sample processing timing: Rapid processing is crucial to preserve phosphorylation status.

• Subcellular fractionation protocol: When investigating compartment-specific phosphorylation, careful separation of nuclear, mitochondrial, and cytoplasmic fractions is necessary. Studies have shown that phosphorylated PHB localizes primarily to mitochondria, while the interaction between PHB and Akt occurs in the cytoplasm .

• Controls: Include both positive controls (cells with activated Akt signaling) and negative controls (samples treated with Akt inhibitors like GSK690693 or MK-2206). Research has shown that these inhibitors significantly reduce the phosphorylation of PHB at Thr258 .

• Validation strategy: Consider using PHB Thr258Ala mutants as negative controls, as these have been shown to be undetectable by phospho-(Ser/Thr) Akt substrate (PAS) antibodies .

What is the molecular mechanism behind Akt-mediated PHB phosphorylation?

The molecular mechanism underlying Akt-mediated PHB phosphorylation involves several coordinated steps:

• Recognition of consensus motif: Akt specifically recognizes the consensus phosphorylation motif RXRXXp(S/T) present in PHB. Human PHB contains three potential Akt consensus phosphorylation sites at Thr108, Ser151, and Thr258, with Thr258 being confirmed as an authentic Akt phosphorylation site .

• Compartmentalized interaction: Research has revealed that the interaction between PHB and Akt predominantly occurs in the cytoplasm rather than in nuclear or mitochondrial compartments. Western blotting analysis of subcellular fractions has confirmed that active phospho-Akt is present in multiple cellular compartments (nuclear, mitochondrial, and cytoplasmic), but its interaction with PHB is detected only in the cytoplasmic extract .

• Phosphorylation-induced conformational change: Upon phosphorylation at Thr258, PHB undergoes conformational changes that facilitate its translocation to mitochondria. This phosphorylation event serves as a molecular switch controlling PHB's subcellular localization and function .

• Substrate validation: Mutation studies using PHB variants (Thr108Ala, Ser151Ala, and Thr258Ala) have definitively identified Thr258 as the principal Akt phosphorylation site. While phospho-(Ser/Thr) Akt substrate (PAS) antibodies detected phosphorylated Flag-PHB-Thr108Ala and Flag-PHB-Ser151Ala, they failed to detect Flag-PHB-Thr258Ala .

How does PHB phosphorylation at Thr258 influence cancer progression?

The phosphorylation of PHB at Thr258 plays a significant role in cancer progression through multiple mechanisms:

• Enhanced cell proliferation: Research has demonstrated that phosphorylation of PHB at Thr258 is required for cancer cell proliferation. Studies in bladder cancer cells showed that overexpression of wild-type PHB increased cell proliferation, while the phosphorylation-deficient mutant PHB T258A inhibited proliferation .

• Mitochondrial localization: Phosphorylated PHB predominantly localizes to mitochondria in cancer cells. This localization pattern is directly linked to its pro-proliferative function and is abolished when Akt activity is inhibited .

• Clinical correlation: PHB overexpression in bladder cancer tissues correlates with advanced tumor stage, lymph node metastasis, and poorer prognosis. The table below summarizes clinical correlations found in bladder cancer studies:

• Resistance to therapy: The constitutively active phosphomimetic mutant PHB T258D not only significantly induces proliferation but also counteracts the anti-proliferative effects of Akt inhibitors, suggesting that PHB phosphorylation may contribute to therapy resistance mechanisms .

What experimental approaches can be used to study the dynamic process of PHB phosphorylation?

To investigate the dynamic nature of PHB phosphorylation, researchers can employ several sophisticated experimental approaches:

• Phospho-specific antibody-based techniques:

  • Western blotting with Phospho-PHB (Thr258) antibodies to monitor phosphorylation levels under various conditions

  • Immunoprecipitation with PHB antibodies followed by immunoblotting with phospho-(Ser/Thr) Akt substrate (PAS) antibodies to detect phosphorylated PHB

• Genetic approaches:

  • Expression of phosphorylation site mutants: PHB T258A (phosphorylation-deficient) and PHB T258D (phosphomimetic) to study the functional consequences of PHB phosphorylation

  • siRNA knockdown of PHB followed by rescue experiments with wild-type or mutant PHB to establish phosphorylation-specific effects

• Pharmacological interventions:

  • Treatment with Akt inhibitors (such as GSK690693 or MK-2206) to block PHB phosphorylation and monitor subsequent effects on subcellular localization and function

  • Time-course experiments following Akt activation or inhibition to capture the temporal dynamics of PHB phosphorylation

• Subcellular fractionation:

  • Isolation of nuclear, mitochondrial, and cytoplasmic fractions to track the compartment-specific distribution of phosphorylated PHB

  • Co-immunoprecipitation assays in different subcellular fractions to identify compartment-specific interaction partners

How can researchers validate the specificity of Phospho-PHB (Thr258) signals in their experiments?

Validating the specificity of Phospho-PHB (Thr258) signals in research experiments requires a comprehensive approach incorporating multiple complementary strategies:

• Antibody validation controls:

  • Peptide competition assays using the immunizing phosphopeptide (N-I-T(p)-Y-L) to confirm signal specificity

  • Comparison with signals obtained using total PHB antibodies to assess the proportion of phosphorylated protein

  • Use of secondary antibody-only controls to rule out non-specific binding

• Genetic manipulation:

  • Expression of PHB T258A mutant as a negative control, as this variant cannot be phosphorylated at the Thr258 position

  • siRNA knockdown of PHB to confirm that the observed signal decreases with reduced PHB expression

• Pharmacological validation:

  • Treatment with Akt inhibitors (GSK690693, MK-2206) to demonstrate reduced phosphorylation signal

  • Phosphatase treatment of samples to eliminate phosphorylation-dependent signals

• Mass spectrometry:

  • Confirmation of phosphorylation site occupancy through mass spectrometry analysis of immunoprecipitated PHB

  • Quantitative phosphoproteomic analysis to assess relative phosphorylation levels across different experimental conditions

• Functional validation:

  • Correlation of phosphorylation signal with expected biological outcomes, such as increased cell proliferation or mitochondrial localization

  • Rescue experiments using phosphomimetic PHB T258D to restore function in the presence of Akt inhibitors

What are the technical challenges in studying PHB phosphorylation in different subcellular compartments?

Investigating PHB phosphorylation across various subcellular compartments presents several technical challenges that researchers should address:

• Preservation of phosphorylation status:

  • Phosphorylation is a labile modification that can be rapidly lost during sample preparation

  • Subcellular fractionation procedures may activate endogenous phosphatases

  • Solution: Include phosphatase inhibitors in all buffers and maintain samples at 4°C throughout processing

• Cross-contamination between fractions:

  • Mitochondrial, nuclear, and cytoplasmic fractions can be cross-contaminated during isolation

  • Solution: Verify fraction purity using compartment-specific markers (e.g., VDAC for mitochondria, Lamin B for nucleus, GAPDH for cytoplasm)

• Low abundance of phosphorylated species:

  • Phosphorylated PHB may represent only a small fraction of total PHB

  • Solution: Enrich for phosphorylated proteins using phospho-specific antibodies or phosphopeptide enrichment techniques

• Compartment-specific interactions:

  • PHB interacts with Akt in the cytoplasm but not in nuclear or mitochondrial compartments

  • Solution: Perform co-immunoprecipitation experiments from isolated subcellular fractions

• Phosphorylation-induced translocation:

  • PHB phosphorylation induces its translocation between compartments, complicating interpretation of results

  • Solution: Conduct time-course experiments and use phosphomimetic (T258D) or phosphorylation-deficient (T258A) mutants to distinguish cause from effect

How does PHB phosphorylation correlate with clinical outcomes in cancer patients?

Research has established important correlations between PHB phosphorylation and clinical outcomes in cancer patients:

What methods can be used to distinguish between different phosphorylation sites on PHB?

Distinguishing between different phosphorylation sites on PHB requires sophisticated analytical approaches:

• Site-specific phospho-antibodies:

  • Antibodies that specifically recognize individual phosphorylation sites (e.g., Phospho-PHB (Thr258))

  • These enable direct detection of site-specific phosphorylation by Western blotting, immunoprecipitation, or immunohistochemistry

• Mutagenesis approaches:

  • Generation of site-specific mutants (e.g., Thr108Ala, Ser151Ala, Thr258Ala) to eliminate specific phosphorylation sites

  • Subsequent functional analysis to determine the contribution of each site to PHB function

• Phosphopeptide mapping:

  • Digestion of PHB with proteases followed by phosphopeptide enrichment

  • Mass spectrometry analysis to identify and quantify phosphorylation at specific sites

• Kinase assays:

  • In vitro kinase assays using purified Akt and synthetic peptides containing different potential phosphorylation sites

  • Comparison of phosphorylation efficiency across different site-containing peptides

• Computational prediction:

  • Bioinformatic tools like GPS (Group-based Prediction System) can identify potential phosphorylation sites matching the Akt consensus motif RXRXXp(S/T)

  • These predictions can guide experimental validation of novel phosphorylation sites

What are the emerging questions about PHB phosphorylation beyond cancer research?

While much of the current research focuses on cancer, several important questions about PHB phosphorylation remain to be explored in other contexts:

• Role in metabolic regulation:

  • How does PHB phosphorylation at Thr258 influence mitochondrial function and cellular metabolism?

  • Is PHB phosphorylation altered in metabolic disorders, and could it represent a therapeutic target?

• Involvement in aging:

  • Given PHB's role in cellular senescence, how does its phosphorylation status change during aging?

  • Could modulation of PHB phosphorylation affect longevity or age-related pathologies?

• Interaction with other signaling pathways:

  • Beyond Akt, what other kinases might phosphorylate PHB at Thr258 or other sites?

  • How does PHB phosphorylation integrate with other cellular signaling networks?

• Tissue-specific functions:

  • Does the significance of PHB Thr258 phosphorylation vary across different tissues?

  • Are there tissue-specific consequences of altered PHB phosphorylation?

• Role in inflammation and immunity:

  • How does PHB phosphorylation affect inflammatory processes and immune cell function?

  • Could targeting PHB phosphorylation provide new approaches for treating inflammatory disorders?

How can advanced technologies enhance our understanding of PHB phosphorylation dynamics?

Emerging technologies offer new opportunities to deepen our understanding of PHB phosphorylation:

• Live-cell imaging techniques:

  • Phosphorylation biosensors based on fluorescence resonance energy transfer (FRET)

  • These could enable real-time monitoring of PHB phosphorylation in living cells

• Single-cell phosphoproteomics:

  • Analysis of PHB phosphorylation heterogeneity within cell populations

  • Correlation of phosphorylation status with single-cell transcriptomics or metabolomics

• Cryo-electron microscopy:

  • Structural analysis of PHB complexes in different phosphorylation states

  • Insights into how phosphorylation affects protein-protein interactions and complex assembly

• Genome editing technologies:

  • CRISPR-Cas9 knock-in of endogenous tagged PHB or phosphorylation-site mutants

  • This would enable study of phosphorylation under physiologically relevant expression levels

• Systems biology approaches:

  • Integration of phosphoproteomics, transcriptomics, and metabolomics data

  • Mathematical modeling of PHB phosphorylation dynamics and its impact on cellular networks